Press Releases

Jul 26, 2011

Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis Meeting Read more »

April 26, 2011

Announcement: Amunix Signs Research Collaboration with Biogen Idec for Next Generation Long-Lasting Blood Factor Products Read more »

April 15, 2011

Announcement: Biogen Idec Hemophilia celebrates World Hemophilia Day Read more »

December 6, 2010

Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Lasting Recombinant Factor VIII Fc Fusion Protein Read more »

July 12, 2010

Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress Read more »

July 9, 2010

Biogen Idec and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial Read more »

February 18, 2010

Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement Read more »

January 25, 2010

Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapy Read more »

October 19, 2009

Biogen Idec and Biovitrum Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Trial Read more »

Click here for other Biogen Idec press releases